| 영문 | neutropenia | 한글 | 호중성백혈구감소증 |
|---|---|---|---|
| 설명 | 여러 가지 원인으로 호중구의 감소를 일으키는 병태의 총칭이며, 혈액중의 호중구가 2,000/mm3 이하의 상태를 말한다. 원인으로 선천적, 체질적인 것과, 이차적인 것으로 크게 나뉜다. 선천적 또는 체질적인 것에는 유전성호중구감소증, 이자기능부족을 수반하는 호중구감소증, 만성저형성성호중구감소증, 만성무과립구증, 주기성호중구감소증 등이 있다. 이차적인 것에는 약물, 화학물질에 의한 것, 방사선에 의한 것, 감염증, 면역성호중구감소증 등이 있다. 급성, 만성이 있으며, 특히 만성의 호중구감소증에서는 감염이 반복되어서 치료에 대한 반응이 나쁘다. |
||
| AAN | AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o... |
|---|---|
| ADC | AIDS Dementia Complex; AIDS 치매 복합 |
| ARC | AIDS Related Complex; AIDS 관련 복합 |
| INP | idiopathic neutropenia |
| ONMRS | onychotrichodysplasia-neutropenia-mental retardation syndrome |
| AIDS-KS | AIDS-associated Kaposi sarcoma |
|---|---|
| AIDS-KS | AIDS- related Kaposi's sarcoma |
| AIDS-NHL | AIDS-related non-Hodgkin lymphomas |
| ZDV | Zidovudine |
| AZT | and Zidovudine |
self-care (자가 치료
| aids-associated nephropathy | Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients. (12 Dec 1998) |
|---|---|
| zidovudine | <drug> A nucleoside analogue used to slow replication of HIV AZT is approved for the initial treatment of HIV infection. AZT is increasingly administered in combination with other antiviral drugs, especially 3TC (a combination that is under consideration by the FDA as another initial treatment regimen for HIV) as well as ddC (an FDA-approved combination for persons with progressive disease and CD4 cell counts below 300). Possible side effects include bone marrow suppression leading to anaemia, leukopenia or neutropenia nausea, muscle weakness and headaches. (09 Oct 1997) |
| periodic neutropenia | Neutropenia recurring at regular intervals (14 to 45 days), in association with various types of infectious diseases, e.g., stomatitis, cutaneous ulcers, furuncles, arthritis, and others. Synonym: cyclic neutropenia. (05 Mar 2000) |
| cyclic neutropenia | Neutropenia recurring at regular intervals (14 to 45 days), in association with various types of infectious diseases, e.g., stomatitis, cutaneous ulcers, furuncles, arthritis, and others. Synonym: cyclic neutropenia. (05 Mar 2000) |
| neutropenia | <haematology> Leucopenia in which the decrease in white blood cells is chiefly in neutrophils. (18 Nov 1997) |
| AIDS | <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids. Acronym: AIDS (10 May 1997) |
| AIDS-defining illness | <immunology> One of a list of serious illnesses that occurs in HIV-positive individuals and is reason for an AIDS diagnosis according to the CDC's definition of AIDS. Among these conditions are PCP, MAC, AIDS dementia complex, AIDS wasting syndrome, invasive cervical cancer, Kaposi's sarcoma and CMV retinitis. (09 Oct 1997) |
| AIDS dementia | <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting. Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection. (09 Oct 1997) |
| AIDS dementia complex | <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting. Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection. (09 Oct 1997) |
| aids-related complex | A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids. (12 Dec 1998) |
| aids-related opportunistic infections | Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus. (12 Dec 1998) |
| AIDS-related virus | An obsolete term for human immunodeficiency virus. (05 Mar 2000) |
| aids serodiagnosis | Immunologic tests for identification of HIV (HTLV-III/lav) antibodies. They include assays for HIV seropositivity and HIV seronegativity (elisa, immunofluorescence, immunoblot, etc.) that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of aids or aids-related complex. (12 Dec 1998) |
| AIDS test | <investigation> A test which is performed on a standard venipuncture blood specimen which detects the presence of antibodies to HIV (virus). This test may not be positive for 3 to 6 months after infection with HIV. (27 Sep 1997) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|